Nick Dinh
About Nick Dinh
Nick Dinh is a Senior Associate Scientist in Analytical Development at Kite Pharma, where he has worked since 2018. He specializes in developing and optimizing assays and has a background in microbiology with a Bachelor of Science degree from California State University-Long Beach.
Work at Kite Pharma
Nick Dinh has been employed at Kite Pharma since 2018, serving as a Senior Associate Scientist in the Analytical Development department. His role involves conducting advanced analytical studies and developing methodologies to support product release. Dinh has performed a comparison study of established ddPCR instruments with the QXOne ddPCR automated system. He has also conducted a potency IFN-γ co-culture ELISA method fit for purpose study, qualifying existing Autologous methods for Allogeneic testing in quality control.
Education and Expertise
Nick Dinh earned a Bachelor of Science degree in Microbiology from California State University-Long Beach, where he studied from 1994 to 1997. His educational background provides a strong foundation in microbiological principles, which he applies in his current role. Dinh has expertise in various analytical techniques, including ddPCR and ELISA, and he trains colleagues in these methods, enhancing the team's overall proficiency in analytical development.
Background
Prior to his current position at Kite Pharma, Nick Dinh accumulated extensive experience in laboratory settings. He worked as a Laboratory Technician at Specialty Laboratories from 1999 to 2005 and at California Cryobank LLC from 2005 to 2006. Dinh also served as a Senior Principal Associate at Agensys, Inc. from 2006 to 2017. His diverse background in laboratory operations has contributed to his analytical skills and understanding of quality control processes.
Achievements
Throughout his career, Nick Dinh has made significant contributions to analytical development. He incorporated and validated a high throughput DNA extraction method using the Maxwell automated nucleic acid purification system. Additionally, he developed and optimized a cytolytic potency assay platform to support Allogeneic program sample testing and Cryo stability sample testing. These initiatives demonstrate his commitment to advancing methodologies within the field.